This is a Sweden news story, published by Medical and health information, that relates primarily to Mongiu news.
For more Sweden news, you can click here:
more Sweden newsFor more Mongiu news, you can click here:
more Mongiu newsFor more medical innovations news, you can click here:
more medical innovations newsFor more news from Medical and health information, you can click here:
more news from Medical and health informationOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like medical innovations news, you might also like this article about
rectal cancer treatment. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest rectal cancer news, total neoadjuvant treatment news, medical innovations news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
advanced rectal cancerMedical and health information
•85% Informative
A new treatment for locally advanced rectal cancer (LARC) has proved successful enough to avoid surgery and reduce the risk of recurrence.
Researchers in Sweden found that the treatment reduced the existence of tumors by twice the amount as previous approaches.
Treatment could reduce the need for complicated bowel surgery and the subsequent complications that ensue.
In the preceding randomized trial, seven countries, including the U.S. took part.
Mongiu emphasized that while the treatment is theoretically accessible to people around the world, economic disparities will prevent it from happening.
Lower income countries and those with unstable infrastructure may struggle to purchase specialized equipment, trained multidisciplinary teams, and chemotherapy agents needed to administer TNT .
VR Score
83
Informative language
81
Neutral language
66
Article tone
formal
Language
English
Language complexity
71
Offensive language
possibly offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
6
Source diversity
4
Affiliate links
no affiliate links